New pharmacologic strategies for acute neuronal injury

Pharmacotherapy

Volumn 16, Issue 5 I, 1996, Pages 830-848

  Luer, Mark S ^a   Rhoney, Denise H ^b   Hughes, Melody ^c   Hatton, Jimmi ^c  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b DETROIT RECEIVING HOSPITAL   (United States)

^c University of Kentucky   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CALCIUM CHANNEL BLOCKING AGENT; FREE RADICAL; GANGLIOSIDE; GROWTH FACTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEW DRUG; OPIATE AGONIST; SCAVENGER; SOMATOMEDIN C;

CALCIUM HOMEOSTASIS; DRUG EFFECT; DRUG RESEARCH; DRUG SCREENING; HUMAN; NERVE CELL LESION; NERVOUS SYSTEM INJURY; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW;

BRAIN INJURIES; CALCIUM; CALCIUM CHANNELS; CEREBROVASCULAR DISORDERS; FREE RADICALS; HUMANS; NEUROPROTECTIVE AGENTS; RECEPTORS, N-METHYL-D-ASPARTATE; SPINAL INJURIES;

EID: 0029780047     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (242)

1. Astrup J, Siesjö BK, Symon L. Thresholds in cerebral ischemia - the ischemic penumbra. Stroke 1981;12:723-5.
2. Hakim AM. The cerebral ischemic penumbra. Can J Neurol Sci 1987;14:557-9.
3. Fischer M, Jones S, Sacco RL. Prophylactic neuroprotection for cerebral ischemia. Stroke 1994;25:1075-80
4. Siesjö BK. Mechanisms of ischemic brain damage. Crit Care Med 1988;16:954-63.
5. Nilsson B, Norberg K, Nordström CH, Siesjö BK. Rate of energy utilization in the cerebral cortex of rats. Acta Physiol Scand 1975;93(4):569-71.
6. Nordström CH, Siesjö BK. Effects of pentobarbital in cerebral ischemia. Part I. Cerebral energy metabolism during pronounced incomplete ischemia. Stroke 1978;9(4):327-35.
7. Siesjö BK. Cell damage in the brain. A speculative synthesis. J Cereb Blood Flow Metab 1981;1(2):155-85.
8. Siesjö BK. Cerebral circulation and metabolism. J Neurosurg 1984;60:883-908.
9. Siesjö BK. Basic mechanisms of traumatic brain injury. Ann Emerg Med 1993;22:959-69.
10. McBurney RN, Daly D, Fischer JB, et al. New CNS-specific calcium antagonists. J Neurotrauma 1992;9(suppl 2): S531-43.
11. Hirsch JA, Gibson GE. Selective alteration of neurotransmitter release by low oxygen in vitro. Neurochem Res 1984;9: 1039-49.
12. Brinley FJJ, Tiffert T, Scarpa A. Mitochondria and other calcium buffers of squid axon studied in situ. J Gen Physiol 1978;72:101-27.
13. Vink R, Head VA, Rogers PM, McIntosh TK, Faden AI. Mitochondrial metabolism following traumatic brain injury in rats. J Neurotrauma 1990;7(1):21-7.
14. Vink R, McIntosh TK, Weiner MW, Faden AI. Effects of traumatic brain injury on cerebral high-energy phosphates and pH: a 31P magnetic resonance spectroscopy study. J Cereb Blood Flow Metab 1987;7:563-71.
15. Vink R, Faden AI, McIntosh TK. Changes in cellular bioenergetic state following graded traumatic brain injury in rats: determination of phosphorus 31 magnetic resonance spectroscopy. J Neurotrauma 1988;5(4):315-30.
16. Kemp JA, Leeson PD. The glycine site of the NMDA receptor - five years on. Trends Pharmacol Sci 1993;14:20-5.
17. Johnson JW. The NMDA receptor and its modulation at the glycine binding site. In: Kozikowski AP, ed. Neurobiology of the NMDA receptor, from chemistry to clinic. New York: VCH Publishers, 1991:67-89.
18. 2+ of NMDA responses in spinal cord neurons [letter]. Nature 1984;309:261-3.
19. Nowak L, Bregestovski P, Ascher P, Herbet A, Prochiantz A. Magnesium gates glutamate-activated channels in mouse central neurones [letter]. Nature 1984;307:462-5.
20. MacDonald JF, Porietis AV. DL-Quisqualic and L-aspartic acids activate separate excitatory conductances in cultured spinal cord neurons. Brain Res 1982;245:175-8.
21. Rana RS, Hokin LE. Role of phosphoinositides in transmembrane signaling. Physiol Rev 1990;70(1):115-64.
22. Majerus PW. Inositol phosphate biochemistry. Annu Rev Biochem 1992;61:225-50.
23. Eisner DA, Lederer WJ. Na-Ca exchange: stoichiometry and electrogenicity. Am J Physiol 1985;248:C189-202.
24. Sanchez-Armass S, Blaustein MP. Role of sodium-calcium exchange in regulation of intracellular calcium in nerve terminals. Am J Physiol 1987;252:C595-603.
25. Siesjö BK, Bengtsson F, Grampp W, Theander S. Calcium, excitotoxins, and neuronal death in the brain. Ann NY Acad Sci 1989;568:234-51.
26. Bignami A, Clark K. Non-phosphorylated and phosphorylated neurofilaments in hypothyroid cat cerebellum. Brain Res 1985;409(1):143-5.
27. Iwasaki Y, Yamamoto H, Izuka H, Yamamoto T, Konno H. Suppression of neurofilament degradation by protease inhibitors in experimental spinal cord injury. Brain Res 1987;406(1-2):99-104.
28. 2+, and its effect on the neurofilament triplet. J Neurosci Res 1985;13:391-403.
29. Pant NC, Gainer H. Properties of a calcium-activated protease in squid axoplasm which selectively degrades neurofilament proteins. J Neurobiol 1980;11(1):1-12.
30. Schlaepfer WW. Calcium-induced degeneration of axoplasm in isolated segments of rat peripheral nerve. Brain Res 1974;69:203-15.
31. Schlaepfer WW, Zimmerman UJ. Mechanisms underlying the neuronal response to ischemic injury. Calcium-activated proteolysis of neurofilaments. Prog Brain Res 1985;63:185-96.
32. Anderson DK, Saunders RD, Demediuk P, et al. Lipid hydrolysis and peroxidation in injured spinal cord: partial protection with methylprednisolone or vitamin E and selenium. Cent Nerv Syst Trauma 1985;2(4):257-267.
33. Bazan NG, Rodriguez De Turco EB. Membrane lipids in the pathogenesis of brain edema: phospholipids and arachidonic acid, the earliest membrane components changed at the onset of ischemia. In: Cervos-Narro J, Ferszt R, eds. Advances of neurology. New York: Raven Press 1980:197-204.
34. Chan PH, Yurko M, Fishman RA. Phospholipid degradation and cellular edema induced by free radicals in brain cortical slices. J Neurochem 1982;38:525-31.
35. Demediuk P, Faden AI, Romhanyi R, Vink R, McIntosh TK. Traumatic brain injury in the rat: effects on lipid metabolism, tissue magnesium, and water content. J Neurotrauma 1988;5(2):105-19.
36. Demediuk P, Daly MP, Faden AI. Changes in free fatty acids, phospholipids, and cholesterol following impact injury to the rat spinal cord. J Neurosci Res 1989;23(1):95-106.
37. Farooqui AA, Taylor WA, Horrocks LA. Phospholipases, lysophospholipases, and lipases and their involvement in various diseases. Neurochem Pathol 1987;7(2):99-128.
38. Horrocks LA, Demediuk P, Saunders RD, et al. The degradation of phospholipids, formation of metabolites of arachidonic acid, and demyelination following experimental spinal cord injury. Cent Nerv Syst Trauma 1985;2:115-20.
39. Clendenon NR, Allen N, Ito T, Gordon WA, Yashon D. Response of lysosomal hydrolases of dog spinal cord and cerebrospinal fluid to experimental trauma. Neurology 1978;28:78-84.
40. Greenberg J, McKeever PE, Balentine JD. Lysosomal activity in experimental spinal cord trauma: an ultrastructural cytochemical evaluation. Surg Neurol 1978;9(6):361-4.
41. Goldman SS, Elowitz E, Flamm ES. Effect of traumatic injury on membrane phosphatase activity in cat spinal cord. Exp Neurol 1983;82:650-62.
42. Milde LN. Pathophysiology of ischemic brain injury. Crit Care Clin 1989;5(4):729-53.
43. van den Kerckhoff W, Hossmann KA, Hossmann V. No effect of prostacyclin on blood flow, regulation of blood flow and blood coagulation following global cerebral ischemia. Stroke 1983;14:724-30.
44. Chan PH, Fishman RA, Lee JL. Arachidonic acid induced swelling in incubated rat brain cortical slices: effect of bovine free serum albumin. Neurochem Res 1984;5:629-40.
45. Pickard JD. Role of prostaglandins and arachidonic acid derivatives in the coupling of cerebral blood flow to cerebral metabolism. J Cerebral Blood Flow Metab 1981;1:361-84.
46. 2 radicals in arachidonate-induced increased blood-brain barrier permeability to proteins. Am J Physiol 1986;251(4):H693-9.
47. Demopoulos HB, Flamm ES, Pietronigro DD, Seligman ML. The radical pathology and the microcirculation in the major central nervous system disorders. Acta Physiol Scand 1980;492(suppl):91-119.
48. Taube H. Mechanisms of oxidation with oxygen. J Gen Physiol 1965;49:29-35.
49. Reilly PM, Schiller HJ, Bulkley GB. Reactive oxygen metabolites in shock. In: Wilmore DW, Brennan MF, Harken AH, Holcroft JW, Meakins JL, eds. Scientific American surgery. New York: Scientific American, 1988-1994:section 4, 8:1-32.
50. Clark IA, Cowden WB, Hunt NH. Free radical-induced pathology. Med Res Rev 1985;5(3):297-332.
51. Kaplan J, Dimlich RV, Biros MH, Hedges J. Mechanisms of ischemic cerebral injury. Resuscitation 1987;15:149-69.
52. Bechman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990;87:1620-4.
53. Armstead WM, Mirro R, Busija DW, Leffler CW. Postischemic generation of superoxide anion by newborn pig brain. Am J Physiol 1988;255:H401-3.
54. Cino M, Del Maestro RF. Generation of hydrogen peroxide by brain mitochondria: the effect of reoxygenation following postdecapitative ischemia. Arch Biochem Biophys 1989;269:623-38.
55. Hall ED, Yonkers PA, Andrus PK, Cox JW, Anderson DK. Biochemistry and pharmacology of lipid antioxidants in acute brain and spinal cord injury. J Neurotrauma 1992;9(suppl 2):S425-42.
56. Del Maestro RF. An approach to free radicals in medicine and biology. Acta Physiol Scand 1980;492:153-68.
57. Mickel HS, Vaishnav YN, Kempski O, von Lubitz D, Weiss JF, Feuerstein G. Breathing 100% oxygen after global brain ischemia in Mongolian gerbils results in increased lipid peroxidation and increased mortality. Stroke 1987;18:426-30.
58. Beckman JS, Campbell GA, Hannan CJ, Karfias CS, Freeman BA. Involvement of superoxide and xanthine oxidase with death due to cerebral ischemia-induced seizures in gerbils. In: Rotilio G, ed. Superoxide and superoxide dismutase in chemistry, biology, and medicine. New York: Elsevier, 1986:602-7.
59. Kinuta Y, Kimura M, Itokawa Y, Ishikawa M, Kikuchi H. Changes in xanthine oxidase in ischemic rat brain. J Neurosurg 1989;71:417-20.
60. McCord JM. Oxygen-derived radicals in postischemic tissue injury. N Engl J Med 1985;312:159-63.
61. Traystman RJ, Kirsch JR, Koehler RC. Oxygen radical mechanisms of brain injury following ischemia and reperfusion. J Appl Physiol 1991;71(4):1185-95
62. 2 and indomethacin prevent impairment of postischemic brain reperfusion in the dog. Stroke 1979;10:629-34.
63. Biemond P, van Eijk HG, Swaak AJ, Koster JF. Iron mobilization from ferritin by superoxide derived from stimulated polymorphonuclear leukocytes: possible mechanism in inflammation diseases. J Clin Invest 1984;73:1576-9.
64. Palmer RM, Moncada S. A novel citrulline-forming enzyme implicated in the formation of nitric oxide by vascular endothelial cells. Biochem Biophys Res Commun 1989;158:348-52.
65. Garthwaite J, Garthwaite G, Palmer RM, Moncada S. NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices. Eur J Pharmacol 1989;172:413-16.
66. Schiller HJ, Reilly PM, Bulkley GB. Antioxidant therapy. Crit Care Med 1993;21:S92-102.
67. Bannister JV, Bannister WH, Rotilio G. Aspects of the structure, function, and applications of superoxide dismutase. CRC Crit Rev Biochem 1987;22:111-80.
68. Forman HJ, Fisher AB. Antioxidant defenses. In: Gilbert DL, ed. Oxygen and living processes an interdisciplinary approach. New York: Springer-Verlag, 1981:235-49.
69. Flohe L. Glutathione peroxidase brought into focus. In: Pryor WA, ed. Free radicals in biology, vol IV. New York: Academic Press, 1980:223-54.
70. Packer JE, Slater TF, Wilson RI. Direct observation of a free radical interaction between vitamin E and vitamin C. Nature 1979;278:737-8.
71. Witting LA. Vitamin E and lipid antioxidants in free-radical initiated reactions. In: Pryor WA, ed. Free radicals in biology, vol IV. New York: Academic Press, 1980:295-319.
72. Hall ED. Intensive anti-oxidant pretreatment retards motor nerve degeneration. Brain Res 1987;413(1):175-8.
73. Hall ED, Braughler JM. Role of lipid peroxidation in post-traumatic spinal cord degeneration: a review. Cent Nerv Syst Trauma 1986;3(4):281-94.
74. Pietronigro DD, Hovsepian M, Demopoulos HB, Flamm ES. Loss of ascorbic acid from injured feline spinal cord. J Neurochem 1983;41:1072-6.
75. Pietronigro DD, DeCrescito V, Tomasula JJ, Demopoulos HB, Flamm ES. Ascorbic acid: a putative biochemical marker of irreversible neurologic functional loss following spinal cord injury. Cent Nerv Syst Trauma 1985;2:85-92.
76. Brawn K, Fridovich I. Superoxide radical and superoxide dismutase: threat and defense. Acta Physiol Scand 1980;492:9-18.
77. White BC, Aust DS, Arfors KE, Aronson LD. Brain injury by ischemic anoxia: hypothesis extension - a tale of two ions? Ann Emerg Med 1984;13(9):862-7.
78. Wei EP, Christman CW, Kontos HA, Povlishock JT. Effects of oxygen radicals of cerebral arterioles. Am J Physiol 1985;248:H157-62.
79. Yoshida S, Inoh S, Asano T, et al. Effect of transient ischemia on fatty acids and phospholipids in the gerbil brain. Lipid peroxidation as a possible cause of postischemic injury. J Neurosurg 1980;53:323-31.
80. Mead JF. Free radical mechanisms of lipid damage and consequences for cellular membranes. In: Pryor WA, ed. Free radicals in biology. New York: Academic Press, 1976:51-60.
81. Bresnick E, Bailey G, Bonney RJ, Wightman P. Phospholipase activity in skin after application of phorbol esters and 3-methylcholanthrene. Carcinogenesis 1981; 2(11):1119-22.
82. Bruch RC, Thayer WS. Differential effect of lipid peroxidation on membrane fluidity as determined electron spin resonance probes. Biochem Biophys Acta 1983;733:216-22.
83. Wei EP, Kontos HA, Dietrich WD, Povlishock JT, Ellis EF. Inhibition by free radical scavengers and by cyclooxygenase inhibitors of pial arteriolar abnormalities from concussive brain injury in cats. Circ Res 1981;48:95-103.
84. McCleskey EW, Fox AP, Feldman DH, et al. Omega-conotoxin: direct and persistent blockade of specific types of calcium channels in neurons but not muscle. Proc Natl Acad Sci USA 1987;84(12):4327-31.
85. Nowycky MC, Fox AP, Tsien RW. Long-opening mode of gating of neuronal calcium channels and its promotion by the dihydropyridine calcium channel agonist Bay K 8644. Proc Natl Acad Sci USA 1985;82(7):2178-82.
86. Snyder SH, Reynolds IJ. Calcium-antagonist drugs: receptor interactions that clarify therapeutic effects. N Engl J Med 1985;313:995-1002.
87. Towart R. The selective inhibition of serotonin-induced contractions of rabbit cerebral vascular smooth muscle by calcium-antagonistic dihydropyridines. Circ Res 1981;48:650-7.
88. Kazda S, Towart R. Nimodipine: a new calcium antagonist drug with a preferential cerebrovascular action. Acta Neurochir 1982;63:259-65.
89. Langley MS, Sorkin EM. Nimodipine: a review of its pharmacokinetic and pharmacokinetic properties, and therapeutic potential in cerebrovascular disease. Drugs 1989;37:669-99.
90. Allen GS, Ahn HS, Preziosi TJ, et al. Cerebral arterial spasm - a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med 1983;308(11):619-24.
91. Woodward DK, Hatton J, Chandler MHH, Young AB, Clifton AB. Alpha-1 acid glycoprotein (AAG) concentration and central nervous system drug distribution following subarachnoid hemorrhage (SAH) [abstr]. Am J Hosp Pharm 1993;50:2142.
92. Mee E, Dorrance D, Lowe D, Neil-Dwyer G. Controlled study of nimodipine in aneurysm patients treated early after subarachnoid hemorrhage. Neurosurgery 1988;22(3):484-91.
93. Paci A, Ottaviano P, Trenta A, et al. Nimodipine in acute ischemic stroke: a double-blind controlled study. Acta Neurol Scand 1989;80:282-6.
94. Martínez-Vila E, Guillén F, Villanueva JA, et al. Placebo-controlled trial of nimodipine in the treatment of acute ischemic cerebral infarction. Stroke 1990;21:1023-8.
95. Petruk KC, West M, Mohr G, et al. Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial. J Neurosurg 1988;68:505-17.
96. ++-antagonist, on isolated dog cerebral and mesenteric arteries. Stroke 1983;14:270-5.
97. Haley EC Jr, Kassell NF, Torner JC, Tuskowski LL, Germanson TP. A randomized trial of two doses of nicardipine in aneurysmal subarachnoid hemorrhage. A report of the cooperative aneurysm study. J Neurosurg 1994;80(5):788-96.
98. Grotta JC, Spydell J, Pettigrew C, Ostrow P, Hunter D. The effect of nicardipine on neuronal function following ischemia. Stroke 1986;17:213-19.
99. Milde LN, Milde JH, Michenfelder JD. Delayed treatment with nimodipine improves cerebral blood flow after complete cerebral ischemia in the dog. J Cereb Blood Flow Metab 1986;6:332-7.
100. Gotoh O, Mohamed A, McCulloch J, Graham DI, Harper AM, Teasdale GM. Nimodipine and the haemodynamic and histopathologic consequences of middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab 1986;6:321-31.
101. Selman WR, Crumrine RC, Seta KA, et al. Evolution of brain damage in reversible focal ischemia in the rat: edema and infarction [abstr]. Stroke 1991;22:16.
102. Kaplan BA, Wang XJ, Pulsinelli WA. The therapeutic window in a rat model of reversible focal ischemia [abstr]. Stroke 1990;21:175.
103. Thayer SA, Murphy SN, Miller RJ. Widespread distribution of dihydropyridine-sensitive calcium channels in the central nervous system. Mol Pharmacol 1986;30:505-9.
104. Weiss JH, Hartley DM, Koh H, Choi DW. The calcium blocker nifedipine attenuates slow excitatory amino acid neurotoxicity. Science 1990;247:1474-7.
105. Albers GW, Goldberg MP, Choi DW. N-methyl-D-aspartate antagonists: ready for clinical trial in brain ischemia? Ann Neurol 1989;25:398-403.
106. Lipton SA, Rosenberg PA. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 1994;330:613-22.
107. Bullock R. Introducing NMDA antagonists into clinical practice: why head injury trials? Br J Clin Pharmacol 1992;34:396-401.
108. Ginsberg MD. Emerging strategies for the treatment of ischemic brain injury. In: Wasman SG, ed. Molecular and cellular approaches in the treatment of neurological disease. New York: Raven Press, 1993:307-37.
109. Kock W, Colpaert FC. Selective blockade of N-methyl-D-aspartate (NMDA)-induced convulsions by NMDA antagonists and putative glycine antagonists: relationship with phencyclidine-like behavioral effects. J Pharmacol Exp Ther 1990;252:345-57.
110. Kemp JA, Foster AC, Wong EHF. Non-competitive antagonists of excitatory amino acid receptors. Trends Neurosci 1987;10:294-8.
111. Chen H-SV, Pellegrini JW, Aggarwal SK, et al. Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity. J Neurosci 1992;12:4427-36.
112. Albers GW. Potential therapeutic uses of N-methyl-D-aspartate antagonists in cerebral ischemia. Clin Neuropharmacol 1990;13(3):177-97.
113. Piercy MF, Hoffman WE, Kaczkofsky P. Functional evidence for PCP-like effects of the anti-stroke candidate MK-801. Psychopharmacology 1988;96:561-2.
114. Nelson SR, Howard RB, Cross RS, Samson F. Ketamine induced changes in regional glucose utilization in the rat brain. Anesthesiology 1980;52:330-4.
115. Hartley DM, Monyer H, Colamarino SA, Choi DW. 7-Chloro-kynurenate blocks NMDA receptor-mediated neurotoxicity in cortical cell cultures [abstr]. Soc Neurosci Abstr 1989;15:762.
116. Patel JB, Ross LE, Duncan B, Asiz M, Salama AI, Valerio M. Administration of glycine antagonists, HA-966 and 7-chlorokynurenic acid reduces ischemic brain damage in gerbils [abstr]. Soc Neurosci Abstr 1989;15:43.
117. McCabe RT, Wasterlain CG, Kuckarczyk N, Sofia RD, Vogel JR. Evidence for anticonvulsant and neuroprotectant action of felbamate mediated by strychnine-insensitive glycine receptors. J Pharmacol Exp Ther 1993;264:1248-52.
118. Wasterlain CG, Adams LM, Hattori H, Schwartz PH. Felbamate reduces hypoxic-ischemic brain damage in vivo. Eur J Pharmacol 1992;212:275-8.
119. Granger DN, McCord JM, Parks DA, Hollwarth WE. Xanthine oxidase inhibitors attenuate ischemia-induced vascular permeability changes in the cat intestine. Gastroenterology 1986;90:80-4.
120. Spector T, Hall WW, Krenitsky TA. Human and bovine xanthine oxidases; inhibition studies with oxypurinol. Biochem Pharmacol 1986;35:3109-14.
121. Parks DA, Williams TK, Beckman JS. Conversion of xanthine dehydrogenase to oxidase in ischemic rat intestine: a reevaluation. Am J Physiol 1988;254:G768-74.
122. Parks DA, Granger DN, Bulkley GB, Shah AK. Soybean trypsin inhibitor attenuates ischemic injury to the feline intestine. Gastroenterology 1985;89:6-12.
123. Halliwell B, Gutteridge JMC. Role of iron in oxygen radical reactions. Methods Enzymol 1984;105:47-56.
124. White BC, Hildebrandt JF, Evans AT, et al. Prolonged cardiac arrest and resuscitation in dogs: brain mitochondrial function with different artificial perfusion methods. Ann Emerg Med 1985;14:383-8.
125. Schurer L, Grogaard B, Gerdin B, Arfors KE. Superoxide dismutase does not prevent delayed hypoperfusion after incomplete cerebral ischemia in the rat. Acta Neurochir 1990;103:163-70.
126. Forsman M, Fleischer JE, Milde JH, Steen PA, Michenfelder JD. Superoxide dismutase and catalase failed to improve neurologic outcome after complete ischemia in the dog. Acta Anaesthesiol Scand 1988;32:152-5.
127. Greenwald RA. Superoxide dismutase and catalase as therapeutic agents for human disease: a critical review. Free Radic Biol Med 1990;8:201-9.
128. Beckman JS, Minor RL, White CW, Repine JE, Rosen GM, Freeman BA. Superoxide dismutase and catalase conjugated to polyethylene glycol increases endothelial enzyme activity and oxidant resistance. J Biol Chem 1988;263:6884-92.
129. Freeman BA, Young SL, Crapo JD. Liposome-mediated augmentation of superoxide dismutase in endothelial cells prevents oxygen injury. J Biol Chem 1983;258:12534-42.
130. 125I-superoxide dismutase in mice. Res Commun Chem Pathol Pharmacol 1976;15:641-54.
131. White CW, Jackson JH, Abuchowski A, et al. Polyethylene glycol-attached antioxidant enzymes decrease pulmonary oxygen toxicity in rats. J Appl Physiol 1989;66:584-90.
132. Imaizumi S, Woolworth V, Fishman RA, Chan PH. Liposome-entrapped superoxide dismutase reduces cerebral infarction in cerebral ischemia in rats. Stroke 1990;21:1312-17.
133. Hallewell RA, Laria I, Tabrizi A, et al. Genetically engineered polymers of human CuZn superoxide dismutase. J Biol Chem 1989;264:5260-8.
134. 2 toxicity in newborn rat. J Appl Physiol 1987;63:347-52.
135. Turrens JF, Crapo JD, Freeman BA. Protection against oxygen toxicity by intravenous injection of liposome-entrapped catalase and superoxide dismutase. J Clin Invest 1984;73:87-95.
136. Chan PH, Longar S, Fishman RA. Protective effects of liposome-entrapped superoxide dismutase on posttraumatic brain edema. Ann Neurol 1987;21:540-7.
137. Matsumiya N, Koehler RC, Kirsch JR, Traystman RJ. Conjugated superoxide dismutase reduces extent of caudate injury after transient focal ischemia in rats. Stroke 1991;21:1193-1200.
138. Liu TH, Beckman JS, Freeman BA, Hogan EL, Hsu CY. Polyethylene-glycol-conjugated superoxide dismutase and catalase reduce ischemic brain injury. Am J Physiol 1989;256:H589-93.
139. Muizelaar JP, Marmarou A, Yound HG, et al. Improving the outcome of severe head injury with the oxygen radical scavenger polyethylene glycol-conjugated superoxide dismutase: a phase II trial. J Neurosurg 1993;78:375-82.
140. Darr DJ, Yanni S, Pinnell SR. Protection of Chinese hamster ovary cells from paraquat-mediated cytotoxicity by a low molecular weight mimic of superoxide dismutase (DF-Mn). Free Radic Biol Med 1988;4:357-63.
141. Mitchell JB, Samuni A, Krishna MC, et al. Biologically active metal-independent superoxide dismutase mimics. Biochemistry 1990;29:2802-7.
142. Anbar M, Meyerstein D, Neta P. Reactivity of aliphatic compounds towards hydroxyl radicals. J Chem Soc 1966;B:742-7.
143. Pirisino R, DiSimplicio P, Ignesti G, Bianchi G, Barbera P. Sulfhydryl groups and peroxidase-like activity of albumin as scavenger of organic peroxides. Pharmacol Res Comm 1988;20:545-52.
144. Jacob SW, Herschler R. Pharmacology of DMSO. Cryobiology 1986;23:14-27.
145. Portz SJ, Lesnefsky EJ, Van Benthuysen KM, et al. Dimethylthiourea, but not dimethylsulfoxide, reduces canine myocardial infarct size. Free Radic Biol Med 1989;7:53-8.
146. Clark WM, Hotan T, Lauten JD, Coull BM. Therapeutic efficacy of tirilazad in experimental multiple cerebral emboli: a randomized, controlled trial. Crit Care Med 1994;22:1161-6.
147. Bracken MD, Shepard MJ, Collins EF, et al. A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal cord injury. N Engl J Med 1990;322:1405-11.
148. Fukuzawa K, Takase S, Tsukatini H. The effect of concentration of the antioxidant effectiveness of α-tocopherol induced by superoxide free radicals. Arch Biochem Biophys 1985;240:117-20.
149. Tappel AI. Vitamin E and free radical peroxidation of lipids. Ann NY Acad Sci 1972;203:12-28.
150. Yoshida S, Busto R, Santiso M, Ginsberg MD. Brain lipid peroxidation induced by postischemic reoxygenation in vitro: effect of vitamin E. J Cereb Blood Flow Metab 1984;4:466-9.
151. Yamamoto M, Shima T, Uozumi T, Sogabe T, Yamade K, Kawasaki T. A possible role of lipid peroxidation in cellular damages caused by cerebral ischemia and the protective effect of alpha-tocopherol administration. Stroke 1983;14:977-82.
152. Suzuki J, Abiko H, Mizoi K, Oba M, Yoshimoto T. Protective effect of phenytoin and its enhanced action by combined administration of mannitol and vitamin E in cerebral ischemia. Acta Neurochir (Wien) 1987;88:56-64.
153. Fleischer JE, Lanier WL, Milde JH, Michenfelder JD. Failure of deferoxamine, an iron chelator, to improve neurologic outcome following complete cerebral ischemia in dogs. Stroke 1987;18:124-7.
154. Machlin LJ, Gabriel E. Kinetics of tissue alpha tocopherol uptake and depletion following administration of high levels of vitamin E. Ann NY Acad Sci USA 1982;393:48-59.
155. Dearden NM, Gibson JS, McDowall DG, Gibson RM, Cameron MM. Effect of high-dose dexamethasone on outcome from severe head injury. J Neurosurg 1986;64:81-8.
156. Braakman R, Schouten HJA, Blaauw-Van Dishoeck M, Minderhoud JM. Mega-dose steroids in severe head injury. J Neurosurg 1983;58:326-30.
157. Plum F. Effects of steroids on experimental cerebral infarction. Arch Neurol 1963;9:571-3.
158. Ito U, Ohno K, Suganuma Y, Suzuki K, Inaba Y. Effect of steroid on ischemic brain edema. Analysis of cytotoxic and vasogenic edema occurring during ischemia and after restoration of blood flow. Stroke 1980;11:166-82.
159. Siegel BA, Studer RK, Potchen EJ. Steroid therapy of brain edema. Ineffectiveness in experimental cerebral microembolism. Arch Neurol 1972;27:209-12.
160. Patten BM, Mendell J, Bruun B, Curtin W, Carter S. Double-blind study of the effects of dexamethasone on acute stroke. Neurology 1972;22:377-83.
161. Jastremski M, Sutton TK, Vaagenes P, Abramson N, Heiselman D, Safar P. Glucocorticoid treatment does not improve neurological recovery Following cardiac arrest. Brain Resuscitation Clinical Trial and Study Group. JAMA 1989;262:3427-30.
162. Hall ED. High-dose glucocorticoid treatment improves neurological recovery in head-injured mice. J Neurosurg 1985;62;882-5.
163. Hall ED, Braughler JM. Acute effects of intravenous glucocorticoid pretreatment on the in vitro peroxidation of cat spinal cord tissue. Exp Neurol 1981;73:321-4.
164. +)-ATPase activity; dose-response analysis during 1st hour after contusion injury in the cat. J Neurosurg 1982;57:247-53.
165. Anderson DK, Means ED, Water TR, Green ES. Microvascular perfusion and metabolism in injured spinal cord after methylprednisolone treatment. J Neurosurg 1982;56:106-13.
166. Braughler JM, Hall ED. Lactate and pyruvate metabolism in injured cat spinal cord before and after a single large intravenous dose of methylprednisolone. J Neurosurg 1983;59:256-61.
167. Braughler JM, Hall ED. Effects of multi-dose methylprednisolone sodium succinate administration on injured cat spinal cord neurofilament degradation and energy metabolism. J Neurosurg 1984;61:290-5.
168. Hall ED, Wolf DL, Braughler JM. Effects of a single large dose of methylprednisolone sodium succinate on experimental posttraumatic spinal cord ischemia: dose-response and time-action analysis. J Neurosurg 1984;61:124-30.
169. Young W, Flamm ES. Effect of high-dose corticosteroid therapy on blood flow, evoked potentials, and extracellular calcium in experimental spinal injury. J Neurosurg 1982;57:667-73.
170. Robertson CS, Goodman JC, Narayan RK, Contant CF, Grossman RG. The effect of glucose administration on carbohydrate metabolism after head injury. J Neurosurg 1991;74(1):43-50.
171. Kolpek JH, Ott LG, Record KE, et al. Comparison of urinary urea nitrogen excretion and measured energy expenditure in spinal cord injury and nonsteroid-treated severe head injury patients. J Parenteral Enteral Nutr 1989;13:277-80.
172. Sieber FE, Traystman RJ. Special issues: glucose and the brain. Crit Care Med 1991;20:104-14.
173. Gudeman ST, Miller JD, Becker DP. Failure of high-dose steroid therapy to influence intracranial pressure in patients with severe head injury. J Neurosurg 1979;51:301-6.
174. DeMaria EJ, Reichman W, Kenney PR, Armitage JM, Gann DS. Septic complications of corticosteroid administration after central nervous system trauma. Ann Surg 1985;202:248-52.
175. Deutschman CS, Konstantinides FN, Raup S, Cerra FB. Physiological and metabolic response to isolated closed-head injury. Part 2. Effects of steroids on metabolism. Potentiation of protein wasting and abnormalities of substrate utilization. J Neurosurg 1987;66:388-95.
176. Robertson CS, Clifton GL, Goodman JC. Steroid administration and nitrogen excretion in the head-injured patient. J Neurosurg 1985;63:714-18.
177. Hoyt DB, Dzkan AN, Hansbrough JF, Marshall L, van Berkum-Clark M. Head injury: an immunologic deficit in T-cell activation. J Trauma 1990;30:759-66.
178. Quattrocchi KB, Frank EH, Miller CH, et al. Suppression of cellular immune activity following severe head injury. J Neurotrauma 1990;7:77-87.
179. Quattrocchi KB, Frank EH, Miller CH, Amin A, Issel BW, Wagner FC Jr. Impairment of helper T-cell function and lymphokine-activated killer cytotoxicity following severe head injury. J Neurosurg 1991;75:766-73.
180. Cushing HC. Peptic ulcers and the interbrain. Surg Gynecol Obstet 1932;55:1-34.
181. Kamada T, Fusamoto H, Kawano S, Noguchi M, Hiramatsu K. Acute gastrointestinal lesions in head injury. Am J Gastroenterol 1977;68:249-53.
182. Galandiuk S, Raque G, Appel S, Polk HC Jr. The two-edged sword of large-dose steroids for spinal cord trauma. Ann Surg 1993;218(4):419-25.
183. Hall ED, McCall JM, Chase RL, Yonkers PA, Braughler JM. A nonglucocorticoid steroid analog of methylprednisolone duplicates its high-dose pharmacology in models of central nervous system trauma and neuronal membrane damage. J Pharmacol Exp Ther 1987;242:137-242.
184. Boveris A, Chance B. The mitochondrial generation of hydrogen peroxide: general properties and effect of hyperbaric oxygen. Biochem J 1973;123:707-16.
185. Hall ED, Yonkers PA, McCall JM, Braughler JM. Effect of the 21-aminosteroid U74006F on experimental head injury in mice. J Neurosurg 1988;68:456-61.
186. Braughler JM, Pregenzer JF, Chase RL, Duncan LA, Jacobsen EJ, McCall JM. Novel 21-aminosteroids as potent inhibitors of iron-dependent lipid peroxidation. J Biol Chem 1987; 262:10438-40.
187. Braughler JM, Pregenzer JF. The 21-aminosteroid inhibitors of lipid peroxidation: reactions with lipid peroxyl and phenoxyl radicals. Free Radical Biol Med 1989;7:125-30.
188. Hall ED, Pazara KE, Braughler JM. Effect of tirilazad mesylate on postischemic lipid peroxidation and recovery of extracellular calcium ingerbils. Stroke 1991;22:361-6.
189. Hall ED, Yonkers PA, Horan KL, Braughler JM. Correlation between attenuation of posttraumatic spinal cord ischemia and preservation of vitamin E by the 21-aminosteroid U-74006F: evidence for an in vivo antioxidant action. J Neurotrauma 1989;6:169-76.
190. Hall ED, Pazara KE. Effects of novel 21-aminosteroid antioxidants on postischemic neuronal degeneration. In: Ginsberg MD, Dietrich WD, eds. Cerebrovascular diseases. New York: Raven Press, 1989:387-91.
191. Hall ED. Effect of the 21-aminosteroid U74006F on posttraumatic spinal cord ischemia. J Neurosurg 1988;68:462-5.
192. Zuccarello M, Marsch JT, Schmitt G, Woodward J, Anderson DK. Effect of the 21-aminosteroid U-74006F on cerebral vasospasm following subarachnoid hemorrhage. J Neurosurg 1989;71:98-104.
193. Dimlich RVW, Tornheim PA, Kindel RM, Hall ED, Braughler JM, McCall JM. Effects of a 21-aminosteroid (U-74006F) on cerebral metabolites and edema after severe experimental head trauma. In: Long D, ed. Advances in neurology, vol 52. New York: Raven Press, 1990:365-75.
194. Skaper SD, Katoh-Semba R, Varon S. GM1 ganglioside accelerates neunte outgrowth from primary peripheral and central neurons under selected culture conditions. Dev Brain Res 1985;23:19-26.
195. Leon A, Dal Toso R, Presti D, et al. Development and survival of neurons in dissociated fetal mesencephalic serum-free cell cultures. II. Modulatory effects of gangliosides. J Neurosci Res 1988;8:746-53.
196. Vaccarino F, Guidotti A, Costa E. Ganglioside inhibition of glutamate mediated protein kinase C translocation in primary cultures of cerebellar neurons. Proc Natl Acad Sci USA 1987;84:8707-11.
197. Favaron M, Manev H, Alho H, et al. Gangliosides prevent glutamate and kainate neurotoxicity in primary neuronal cultures of neonatal rat cerebellum and cortex. Proc Natl Acad Sci USA 1988;85:7351-5.
198. Dal Toso R, Skaper SD, Ferrari G, Vantini G, Toffano G, Leon A. Ganglioside involvement in membrane-mediated transfer of trophic information: relationship to GM1 effects following CNS injury. In: Stein DG, Sabel BA, eds. Pharmacological approaches to the treatment of brain and spinal cord injury. New York: Plenum Press, 1988:143-65.
199. +)ATPase after nigrostriatal transection. Brain Res 1986;377:292-7.
200. Karpiak SE, Li YS, Mahadik SP. Ganglioside treatment: reduction of CNS injury and facilitation of functional recovery. Brain Injury 1987;1:161-70.
201. Komatsumoto S, Greenberg JH, Hickey WF, Reivich M. Effect of the ganglioside GM1 on neurologic function, electroencephalogram amplitude, and histology in chronic middle cerebral artery occlusion in cats. Stroke 1988;19:1027-35.
202. Gorio A, Ferrari G, Fusio M, et al. Gangliosides and their effects on rearranging peripheral and central neural pathways. Cent Nerv Syst Trauma 1984;1:29-37.
203. Sabel BA, Slavin MD, Stein DG. GM1 ganglioside treatment facilitates behavioral recovery from bilateral brain damage. Science 1984;225:340-2.
204. Karpiak SE. Exogenous gangliosides enhance recovery from CNS injury. Adv Exp Med Biol 1984;174:489-97.
205. Geisler FH, Dorsey FC, Coleman WP. Recovery of motor function after spinal-cord injury - a randomized, placebo-controlled trial with GM-1 ganglioside. N Engl J Med 991;324:1829-38.
206. Roemmer E. Arzneimitter-induziertes Guillain Barré-Syndrom. Dtsch Arztebl 1989;96:4452.
207. Faden AI, Jacobs TP, Holaday JW. Opiate antagonist improves neurologic recovery after spinal injury. Science 1981;211:493-4.
208. Faden AI, Jacobs TP, Mougey E, Holaday JW. Endorphins in experimental spinal cord injury: therapeutic effect of naloxone. Ann Neurol 1981;10:326-32.
209. Flamm ES, Young W, Demopoulos HB, Decrescito V, Tomasula JJ. Experimental spinal cord injury: treatment with naloxone. Neurosurgery 1982;10:227-31.
210. Holaday JW, Faden AI. Naloxone acts as central opiate receptor to reverse hypotension, hypothermia, and hypoventilation in spinal shock. Brain Res 1980;189:295-9.
211. Young W, Flamm ES, Demopoulos HB, Tomasula JJ, Descrescito V. Naloxone ameliorates post-traumatic ischemia in experimental spinal contusion. J Neurosurg 1981;55:209-19.
212. Khachaturian H, Lewis ME, Schafer MK-H, Watson SJ. Anatomy of CNS opioid systems. Trends Neurosci 1985;1:111-19.
213. McIntosh TK, Head VA, Faden AI. Alterations in regional concentrations of endogenous opioids following traumatic brain injury in the cat. Brain Res. 1987;425:225-33.
214. Faden AI. Neuropeptides and central nervous system injury. Arch Neurol 1986;43:501-4.
215. Faden AI, Sacksen I, Nobel LJ. Opiate receptor antagonist nalmefene improves neurological recovery after traumatic spinal cord injury in rats through a central mechanism. J Pharmacol Exp Ther 1988;245:742-8.
216. West M, Labella FS, Havlicet V, Parkinson D. Cerebral concussion in rats rapidly induces hypothalamic-specific effects on opiate and cholinergic receptors. Brain Res 1981;225:271-7.
217. McIntosh TK, Hayes RL, Dewitt DS, Agura V, Faden AI. Endogenous opioids may mediate secondary damage after experimental brain injury. Am J Physiol 1987;253:E565-74.
218. Hayes RL, Lyeth GB, Jenkins LW, et al. Laboratory studies of opioid mechanisms of mechanical brain injury: possible protective role for certain endogenous opioids. J Neurosurg 1990;72:252-61.
219. Lyeth BG, Jiang JY, Harmon RJ, Dixon CE, Jenkins LW, Hayes RL. Mu opioid agonist protects against neurological deficits following traumatic brain injury in the rat. J Neurotrauma 1990;9:143-7.
220. Dimitrijevic MR. Restorative neurology of head injury. J Neurotrauma 1989;6:25-9.
221. Edwards OM, Clark JD. Post-traumatic hypopituitarism. Six cases and a review of the literature. Medicine 1986;65:281-90.
222. King LR, Knowles HC Jr, McLaurin RL, Brielmaier J, Perisutti G, Piziak VK. Pituitary hormone response to head injury. Neurosurgery 1981;9:229-35.
223. Gottardis M, Nigitsch C, Schmutzhard E, et al. The secretion of human growth hormone stimulated by human growth hormone releasing factor following severe cranio-cerebral trauma. Intensive Care Med 1990;16:163-6.
224. Luer MS, Hatton J, Rapp RP, McClain CJ, Young B. Positive nitrogen balance in moderate to severe closed head injury following administration of insulin-like growth factor I [abstr]. Pharmacotherapy 1993;13(3):285.
225. Anonymous. The role of insulin-like growth factors in the nervous system. Washington, DC: Proceedings of the New York Academy of Sciences, 1992.
226. Skottner A, Arrhenius-Nyberg V, Kanje M, Fryklund L. Anabolic and tissue repair functions of recombinant IGF-I. Acta Paediatr Scand 1990;367:63-6.
227. Recio-Pinto E, Ishii DN. Insulin and related growth factors: effects on the nervous system and mechanism for neurite growth and regeneration. Neurochem Int 1988;12:397-414.
228. Gluckman P, Klempt N, Jian G, et al. A role for IGF-I in the rescue of CNS neurons following hypoxic-ischemic injury. Biochem Biophys Res Commun 1992;182(2):593-9.
229. Kanje M, Skottner A, Sjoberg J, Lundborg G. Insulin-like growth factor I (IGF-I) stimulates regeneration of the rat sciatic nerve. Brain Res 1989;486:396-8.
230. Sjoberg J, Kanje M. Insulin-like growth factor (IGF-I) as a stimulator of regeneration in the freeze-injured rat sciatic nerve. Brain Res 1989;85:102-8.
231. Caroni P, Grandes P. Nerve sprouting in innervated adult skeletal muscle induced by exposure to elevated levels of insulin-like growth factors. J Cell Biol 1990;100:1307-17.
232. Lipton SA. Growth factors for neuronal survival and process regeneration. Implications in the mammalian central nervous system. Arch Neurol 1989;6:1241-8.
233. Cheng B, Mattson MP. IGF-I and IGF-II protect cultured hippocampal and septal neurons against calcium-mediated hypoglycemic damage. J Neurosci 1992;12(4):1558-66.
234. Hefti F, Weiner WJ. Nerve growth factor and Alzheimer's disease. Ann Neurol 1986;20:275-81.
235. Kromer LF. Nerve growth factor treatment after brain injury prevents neuronal death. Science 1987;235:214-16.
236. Williams LR, Varon S, Peterson GM, et al. Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transection. Proc Natl Acad Sci USA 1986;83:9231-5.
237. Morrison RS, Sharma A, De Vellis J, Bradshaw RA. Basic fibroblast growth factor supports the survival of cerebral cortical neurons in primary culture. Proc Natl Acad Sci USA 1986;83:7537-41.
238. Walicke PA, Baird A. Neurotrophic effects of basic and acidic fibroblast growth factors are not mediated through glial cells. J Dev Brain Res 1986;40:71-9.
239. Walicke PA. Basic and acidic fibroblast growth factors have trophic effects on neurons in multiple CNS regions. J Neurosci 1988;8(7):2618-27.
240. Sievers J, Hasumann B, Unsicker K, Berry M. Fibroblast growth factors promote the survival of adult retinal ganglion neurons after transection of the optic nerve. Neurosci Lett 1987;76:157-62.
241. Barbin G, Manthorpe M, Varon S. Purification of chicken ciliary neurotrophic factor. J Neurochem 1984;43:11468-78.
242. Sendtner M, Kreutzberg GW, Thoenen H. Ciliary neurotrophic factor prevents the degeneration of motor neurons after axotomy. Nature 1990;345:440-1.